Treating prostate cancer with anti-erbb2 antibodies

Details Treating prostate cancer with anti-erbb2 antibodies Treating prostate cancer with anti-erbb2 antibodies

Category

A - Human Necessities

Subcategory

61

Subsubcategory

K

IPC codes

A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 16/32 (2006.01)

Type

Patent

Patent number

CA 2383493

Description

The present application discloses treatment of prostate cancer with anti-ErbB2 antibodies.

La présente invention concerne le traitement du cancer de la prostate à l'aide d'anticorps anti-ErbB2.

Affiliated with

Also associated with

Rating

Treating prostate cancer with anti-erbb2 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating prostate cancer with anti-erbb2 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating prostate cancer with anti-erbb2 antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1874748